R0V.F REVENIO GROUP CORP. EO 15

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
10.00 EUR
Close of Nov 12, 2026
9.87 22.95
Market cap
EUR 421M
P/E
24.4x
P/B
2.81x
ROE
4.1%
Dividend yield
2.53%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is R0V.F undervalued?

Graham number
Price10.00
Graham value5.73
Premium74.5%

R0V.F trades 74.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

REVENIO GROUP CORP. EO 15 fundamental analysis

No fundamental analysis for REVENIO GROUP CORP. EO 15 yet.

REVENIO GROUP CORP. EO 15 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About REVENIO GROUP CORP. EO 15

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or eme…

Full company profile